United States Recombinant Glycosylated Proteins Market Report 2017

January 2017 | 124 pages | ID: U0C8B61B537EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Recombinant Glycosylated Proteins

Revenue, means the sales value of Recombinant Glycosylated Proteins

This report studies sales (consumption) of Recombinant Glycosylated Proteins in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Hospira
• Sandoz International
• Teva
• Roche
• Amgen
• Biocon
• Dr. Reddy’s Laboratories
• Celltrion
• Mylan
• Actavis
• Merck
• Taj Pharmaceuticals

Market Segment by States, covering

• California
• Texas
• New York
• Florida
• Illinois

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Erythropoietin (EPO)
• Monoclonal antibodies (mabs)
• Follitropin

Split by applications, this report focuses on sales, market share and growth rate of Recombinant Glycosylated Proteins in each application, can be divided into

• Oncology
• Blood Disorders
• Auto-immune Diseases
• Infectious disease
• Growth Hormone Deficiency

Contents

United States Recombinant Glycosylated Proteins Market Report 2017

1 RECOMBINANT GLYCOSYLATED PROTEINS OVERVIEW

1.1 Product Overview and Scope of Recombinant Glycosylated Proteins
1.2 Classification of Recombinant Glycosylated Proteins
  1.2.1 Erythropoietin (EPO)
  1.2.2 Monoclonal antibodies (mabs)
  1.2.3 Follitropin
1.3 Application of Recombinant Glycosylated Proteins
  1.3.1 Oncology
  1.3.2 Blood Disorders
  1.3.3 Auto-immune Diseases
  1.3.4 Infectious disease
  1.3.5 Growth Hormone Deficiency
1.4 United States Market Size Sales (Volume) and Revenue (Value) of Recombinant Glycosylated Proteins (2011-2021)
  1.4.1 United States Recombinant Glycosylated Proteins Sales and Growth Rate (2011-2021)
  1.4.2 United States Recombinant Glycosylated Proteins Revenue and Growth Rate (2011-2021)

2 UNITED STATES RECOMBINANT GLYCOSYLATED PROTEINS COMPETITION BY MANUFACTURERS

2.1 United States Recombinant Glycosylated Proteins Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Recombinant Glycosylated Proteins Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Recombinant Glycosylated Proteins Average Price by Manufactures (2015 and 2016)
2.4 Recombinant Glycosylated Proteins Market Competitive Situation and Trends
  2.4.1 Recombinant Glycosylated Proteins Market Concentration Rate
  2.4.2 Recombinant Glycosylated Proteins Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES RECOMBINANT GLYCOSYLATED PROTEINS SALES (VOLUME) AND REVENUE (VALUE) BY STATES (2011-2016)

3.1 United States Recombinant Glycosylated Proteins Sales and Market Share by States (2011-2016)
3.2 United States Recombinant Glycosylated Proteins Revenue and Market Share by States (2011-2016)
3.3 United States Recombinant Glycosylated Proteins Price by States (2011-2016)

4 UNITED STATES RECOMBINANT GLYCOSYLATED PROTEINS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

4.1 United States Recombinant Glycosylated Proteins Sales and Market Share by Type (2011-2016)
4.2 United States Recombinant Glycosylated Proteins Revenue and Market Share by Type (2011-2016)
4.3 United States Recombinant Glycosylated Proteins Price by Type (2011-2016)
4.4 United States Recombinant Glycosylated Proteins Sales Growth Rate by Type (2011-2016)

5 UNITED STATES RECOMBINANT GLYCOSYLATED PROTEINS SALES (VOLUME) BY APPLICATION (2011-2016)

5.1 United States Recombinant Glycosylated Proteins Sales and Market Share by Application (2011-2016)
5.2 United States Recombinant Glycosylated Proteins Sales Growth Rate by Application (2011-2016)
5.3 Market Drivers and Opportunities

6 UNITED STATES RECOMBINANT GLYCOSYLATED PROTEINS MANUFACTURERS PROFILES/ANALYSIS

6.1 Hospira
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Recombinant Glycosylated Proteins Product Type, Application and Specification
    6.1.2.1 Erythropoietin (EPO)
    6.1.2.2 Monoclonal antibodies (mabs)
  6.1.3 Hospira Recombinant Glycosylated Proteins Sales, Revenue, Price and Gross Margin (2011-2016)
  6.1.4 Main Business/Business Overview
6.2 Sandoz International
  6.2.2 Recombinant Glycosylated Proteins Product Type, Application and Specification
    6.2.2.1 Erythropoietin (EPO)
    6.2.2.2 Monoclonal antibodies (mabs)
  6.2.3 Sandoz International Recombinant Glycosylated Proteins Sales, Revenue, Price and Gross Margin (2011-2016)
  6.2.4 Main Business/Business Overview
6.3 Teva
  6.3.2 Recombinant Glycosylated Proteins Product Type, Application and Specification
    6.3.2.1 Erythropoietin (EPO)
    6.3.2.2 Monoclonal antibodies (mabs)
  6.3.3 Teva Recombinant Glycosylated Proteins Sales, Revenue, Price and Gross Margin (2011-2016)
  6.3.4 Main Business/Business Overview
6.4 Roche
  6.4.2 Recombinant Glycosylated Proteins Product Type, Application and Specification
    6.4.2.1 Erythropoietin (EPO)
    6.4.2.2 Monoclonal antibodies (mabs)
  6.4.3 Roche Recombinant Glycosylated Proteins Sales, Revenue, Price and Gross Margin (2011-2016)
  6.4.4 Main Business/Business Overview
6.5 Amgen
  6.5.2 Recombinant Glycosylated Proteins Product Type, Application and Specification
    6.5.2.1 Erythropoietin (EPO)
    6.5.2.2 Monoclonal antibodies (mabs)
  6.5.3 Amgen Recombinant Glycosylated Proteins Sales, Revenue, Price and Gross Margin (2011-2016)
  6.5.4 Main Business/Business Overview
6.6 Biocon
  6.6.2 Recombinant Glycosylated Proteins Product Type, Application and Specification
    6.6.2.1 Erythropoietin (EPO)
    6.6.2.2 Monoclonal antibodies (mabs)
  6.6.3 Biocon Recombinant Glycosylated Proteins Sales, Revenue, Price and Gross Margin (2011-2016)
  6.6.4 Main Business/Business Overview
6.7 Dr. Reddy’s Laboratories
  6.7.2 Recombinant Glycosylated Proteins Product Type, Application and Specification
    6.7.2.1 Erythropoietin (EPO)
    6.7.2.2 Monoclonal antibodies (mabs)
  6.7.3 Dr. Reddy’s Laboratories Recombinant Glycosylated Proteins Sales, Revenue, Price and Gross Margin (2011-2016)
  6.7.4 Main Business/Business Overview
6.8 Celltrion
  6.8.2 Recombinant Glycosylated Proteins Product Type, Application and Specification
    6.8.2.1 Erythropoietin (EPO)
    6.8.2.2 Monoclonal antibodies (mabs)
  6.8.3 Celltrion Recombinant Glycosylated Proteins Sales, Revenue, Price and Gross Margin (2011-2016)
  6.8.4 Main Business/Business Overview
6.9 Mylan
  6.9.2 Recombinant Glycosylated Proteins Product Type, Application and Specification
    6.9.2.1 Erythropoietin (EPO)
    6.9.2.2 Monoclonal antibodies (mabs)
  6.9.3 Mylan Recombinant Glycosylated Proteins Sales, Revenue, Price and Gross Margin (2011-2016)
  6.9.4 Main Business/Business Overview
6.10 Actavis
  6.10.2 Recombinant Glycosylated Proteins Product Type, Application and Specification
    6.10.2.1 Erythropoietin (EPO)
    6.10.2.2 Monoclonal antibodies (mabs)
  6.10.3 Actavis Recombinant Glycosylated Proteins Sales, Revenue, Price and Gross Margin (2011-2016)
  6.10.4 Main Business/Business Overview
6.11 Merck
6.12 Taj Pharmaceuticals

7 RECOMBINANT GLYCOSYLATED PROTEINS MANUFACTURING COST ANALYSIS

7.1 Recombinant Glycosylated Proteins Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Recombinant Glycosylated Proteins

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Recombinant Glycosylated Proteins Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Recombinant Glycosylated Proteins Major Manufacturers in 2015
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES RECOMBINANT GLYCOSYLATED PROTEINS MARKET FORECAST (2016-2021)

11.1 United States Recombinant Glycosylated Proteins Sales, Revenue Forecast (2016-2021)
11.2 United States Recombinant Glycosylated Proteins Sales Forecast by Type (2016-2021)
11.3 United States Recombinant Glycosylated Proteins Sales Forecast by Application (2016-2021)
11.4 Recombinant Glycosylated Proteins Price Forecast (2016-2021)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Recombinant Glycosylated Proteins
Table Classification of Recombinant Glycosylated Proteins
Figure United States Sales Market Share of Recombinant Glycosylated Proteins by Type in 2015
Figure Erythropoietin (EPO) Picture
Figure Monoclonal antibodies (mabs) Picture
Figure Follitropin Picture
Table Application of Recombinant Glycosylated Proteins
Figure United States Sales Market Share of Recombinant Glycosylated Proteins by Application in 2015
Figure Oncology Examples
Figure Blood Disorders Examples
Figure Auto-immune Diseases Examples
Figure Infectious disease Examples
Figure Growth Hormone Deficiency Examples
Figure United States Recombinant Glycosylated Proteins Sales and Growth Rate (2011-2021)
Figure United States Recombinant Glycosylated Proteins Revenue and Growth Rate (2011-2021)
Table United States Recombinant Glycosylated Proteins Sales of Key Manufacturers (2015 and 2016)
Table United States Recombinant Glycosylated Proteins Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Recombinant Glycosylated Proteins Sales Share by Manufacturers
Figure 2016 Recombinant Glycosylated Proteins Sales Share by Manufacturers
Table United States Recombinant Glycosylated Proteins Revenue by Manufacturers (2015 and 2016)
Table United States Recombinant Glycosylated Proteins Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Recombinant Glycosylated Proteins Revenue Share by Manufacturers
Table 2016 United States Recombinant Glycosylated Proteins Revenue Share by Manufacturers
Table United States Market Recombinant Glycosylated Proteins Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Recombinant Glycosylated Proteins Average Price of Key Manufacturers in 2015
Figure Recombinant Glycosylated Proteins Market Share of Top 3 Manufacturers
Figure Recombinant Glycosylated Proteins Market Share of Top 5 Manufacturers
Table United States Recombinant Glycosylated Proteins Sales by States (2011-2016)
Table United States Recombinant Glycosylated Proteins Sales Share by States (2011-2016)
Figure United States Recombinant Glycosylated Proteins Sales Market Share by States in 2015
Table United States Recombinant Glycosylated Proteins Revenue and Market Share by States (2011-2016)
Table United States Recombinant Glycosylated Proteins Revenue Share by States (2011-2016)
Figure Revenue Market Share of Recombinant Glycosylated Proteins by States (2011-2016)
Table United States Recombinant Glycosylated Proteins Price by States (2011-2016)
Table United States Recombinant Glycosylated Proteins Sales by Type (2011-2016)
Table United States Recombinant Glycosylated Proteins Sales Share by Type (2011-2016)
Figure United States Recombinant Glycosylated Proteins Sales Market Share by Type in 2015
Table United States Recombinant Glycosylated Proteins Revenue and Market Share by Type (2011-2016)
Table United States Recombinant Glycosylated Proteins Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Recombinant Glycosylated Proteins by Type (2011-2016)
Table United States Recombinant Glycosylated Proteins Price by Type (2011-2016)
Figure United States Recombinant Glycosylated Proteins Sales Growth Rate by Type (2011-2016)
Table United States Recombinant Glycosylated Proteins Sales by Application (2011-2016)
Table United States Recombinant Glycosylated Proteins Sales Market Share by Application (2011-2016)
Figure United States Recombinant Glycosylated Proteins Sales Market Share by Application in 2015
Table United States Recombinant Glycosylated Proteins Sales Growth Rate by Application (2011-2016)
Figure United States Recombinant Glycosylated Proteins Sales Growth Rate by Application (2011-2016)
Table Hospira Basic Information List
Table Hospira Recombinant Glycosylated Proteins Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Hospira Recombinant Glycosylated Proteins Sales Market Share (2011-2016)
Table Sandoz International Basic Information List
Table Sandoz International Recombinant Glycosylated Proteins Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sandoz International Recombinant Glycosylated Proteins Sales Market Share (2011-2016)
Table Teva Basic Information List
Table Teva Recombinant Glycosylated Proteins Sales, Revenue, Price and Gross Margin (2011-2016)
Table Teva Recombinant Glycosylated Proteins Sales Market Share (2011-2016)
Table Roche Basic Information List
Table Roche Recombinant Glycosylated Proteins Sales, Revenue, Price and Gross Margin (2011-2016)
Table Roche Recombinant Glycosylated Proteins Sales Market Share (2011-2016)
Table Amgen Basic Information List
Table Amgen Recombinant Glycosylated Proteins Sales, Revenue, Price and Gross Margin (2011-2016)
Table Amgen Recombinant Glycosylated Proteins Sales Market Share (2011-2016)
Table Biocon Basic Information List
Table Biocon Recombinant Glycosylated Proteins Sales, Revenue, Price and Gross Margin (2011-2016)
Table Biocon Recombinant Glycosylated Proteins Sales Market Share (2011-2016)
Table Dr. Reddy’s Laboratories Basic Information List
Table Dr. Reddy’s Laboratories Recombinant Glycosylated Proteins Sales, Revenue, Price and Gross Margin (2011-2016)
Table Dr. Reddy’s Laboratories Recombinant Glycosylated Proteins Sales Market Share (2011-2016)
Table Celltrion Basic Information List
Table Celltrion Recombinant Glycosylated Proteins Sales, Revenue, Price and Gross Margin (2011-2016)
Table Celltrion Recombinant Glycosylated Proteins Sales Market Share (2011-2016)
Table Mylan Basic Information List
Table Mylan Recombinant Glycosylated Proteins Sales, Revenue, Price and Gross Margin (2011-2016)
Table Mylan Recombinant Glycosylated Proteins Sales Market Share (2011-2016)
Table Actavis Basic Information List
Table Actavis Recombinant Glycosylated Proteins Sales, Revenue, Price and Gross Margin (2011-2016)
Table Actavis Recombinant Glycosylated Proteins Sales Market Share (2011-2016)
Table Merck Basic Information List
Table Taj Pharmaceuticals Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Recombinant Glycosylated Proteins
Figure Manufacturing Process Analysis of Recombinant Glycosylated Proteins
Figure Recombinant Glycosylated Proteins Industrial Chain Analysis
Table Raw Materials Sources of Recombinant Glycosylated Proteins Major Manufacturers in 2015
Table Major Buyers of Recombinant Glycosylated Proteins
Table Distributors/Traders List
Figure United States Recombinant Glycosylated Proteins Production and Growth Rate Forecast (2016-2021)
Figure United States Recombinant Glycosylated Proteins Revenue and Growth Rate Forecast (2016-2021)
Table United States Recombinant Glycosylated Proteins Production Forecast by Type (2016-2021)
Table United States Recombinant Glycosylated Proteins Consumption Forecast by Application (2016-2021)
Table United States Recombinant Glycosylated Proteins Sales Forecast by States (2016-2021)
Table United States Recombinant Glycosylated Proteins Sales Share Forecast by States (2016-2021)